Post by IXICO

Webinar: Understanding Imaging in Parkinson’s Disease Trials: From Eligibility to Efficacy. How can imaging improve decision-making in Parkinson’s disease clinical trials? Hosted by IXICO, join a panel of experts on 24 June 2026 for a practical discussion exploring how PET, SPECT and MRI can support Parkinson’s disease trial design, participant selection, target engagement and outcome assessment. The webinar will cover: • Imaging applications across different trial stages • Selecting biomarkers aligned to study objectives • PET, SPECT and MRI approaches in PD trials • Harmonisation, reproducibility and variability considerations in regulated studies Speakers: • Martijn Muller, Professor of Translational Neuroscience, Manchester Metropolitan University • Kirsi Kinnunen, Principal Biomarker Scientist, IXICO • Moderated by Robin Wolz, CSO and CMO, IXICO Register today: https://lnkd.in/e25xjPwh #ParkinsonsDisease #ClinicalTrials #Neuroscience #Biomarkers #MedicalImaging